Heat Biologics, Inc.

( )
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards



Health Technology » Biotechnology

Company Profile

Heat Biologics, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing proprietary cell based immune pan-antigen cytotoxic therapy (ImPACT). The company's ImPACT platform technology is used to treat patients with a wide array of cancers and infectious diseases. This technology also develops product candidates that consist of live, genetically-modified and irradiated human cancer cells together with immune response stimulator, gp96. Heat Biologics was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Durham, NC.